1. Home
  2. NTWK vs CLNN Comparison

NTWK vs CLNN Comparison

Compare NTWK & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTWK
  • CLNN
  • Stock Information
  • Founded
  • NTWK 1997
  • CLNN 2012
  • Country
  • NTWK United States
  • CLNN United States
  • Employees
  • NTWK N/A
  • CLNN N/A
  • Industry
  • NTWK Computer Software: Prepackaged Software
  • CLNN Biotechnology: Pharmaceutical Preparations
  • Sector
  • NTWK Technology
  • CLNN Health Care
  • Exchange
  • NTWK Nasdaq
  • CLNN Nasdaq
  • Market Cap
  • NTWK 56.1M
  • CLNN 60.3M
  • IPO Year
  • NTWK 1998
  • CLNN N/A
  • Fundamental
  • Price
  • NTWK $4.40
  • CLNN $8.85
  • Analyst Decision
  • NTWK
  • CLNN Strong Buy
  • Analyst Count
  • NTWK 0
  • CLNN 6
  • Target Price
  • NTWK N/A
  • CLNN $32.67
  • AVG Volume (30 Days)
  • NTWK 93.1K
  • CLNN 152.6K
  • Earning Date
  • NTWK 11-12-2025
  • CLNN 11-12-2025
  • Dividend Yield
  • NTWK N/A
  • CLNN N/A
  • EPS Growth
  • NTWK 316.67
  • CLNN N/A
  • EPS
  • NTWK 0.25
  • CLNN N/A
  • Revenue
  • NTWK $66,088,229.00
  • CLNN $286,000.00
  • Revenue This Year
  • NTWK N/A
  • CLNN N/A
  • Revenue Next Year
  • NTWK N/A
  • CLNN $1,363.77
  • P/E Ratio
  • NTWK $17.64
  • CLNN N/A
  • Revenue Growth
  • NTWK 7.65
  • CLNN N/A
  • 52 Week Low
  • NTWK $2.14
  • CLNN $2.28
  • 52 Week High
  • NTWK $5.75
  • CLNN $11.06
  • Technical
  • Relative Strength Index (RSI)
  • NTWK 46.50
  • CLNN 56.73
  • Support Level
  • NTWK $4.30
  • CLNN $7.66
  • Resistance Level
  • NTWK $4.69
  • CLNN $9.77
  • Average True Range (ATR)
  • NTWK 0.18
  • CLNN 0.85
  • MACD
  • NTWK -0.03
  • CLNN -0.07
  • Stochastic Oscillator
  • NTWK 17.33
  • CLNN 56.60

About NTWK NetSol Technologies Inc. Common Stock

NETSOL Technologies Inc is an information technology and enterprise software solutions provider to original equipment manufacturers (OEMs), dealerships, and financial institutions to sell, finance, and lease assets. The firm's products include Transcend Retail, Transcend Finance, Transcend Marketplace, Transcend Consultancy, and Transcend AI Labs, catering to its customers in the different stages of how assets are sold, financed, and leased. Its primary sources of revenue are licensing, subscriptions, modification, enhancement, and support of its suite of financial applications offered to businesses in the finance and leasing space, as well as automotive digital retail. The company has three reportable segments: Asia-Pacific, its key revenue-generating market, North America, and Europe.

About CLNN Clene Inc.

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.

Share on Social Networks: